NeuroSense Therapeutics shares positive results of lead candidate in ALS
The neurodegenerative disease currently affects more than 200,000 people worldwide
Read More
Tag: bayer
Bayer and PCF launch darolutamide challenge awards for prostate cancer
The two projects will be awarded $1m each to support their clinical investigations
Read More
SMC recommends Bayer’s cancer treatments for NHS Scotland use
Eligible patients in Scotland will now have access to Nubeqa and Stivarga
Read More
Bayer buys Vividion Therapeutics for up to $2bn
Acquisition strengthens Bayer’s drug discovery capabilities
Read More
MSD, Bayer’s heart failure med Verquvo gains EU approval
Verquvo cleared for the treatment of symptomatic chronic heart failure in patients with reduced ejection fraction
Read More
Bayer’s Kerendia approved in the US to slow CKD in type 2 diabetes patients
The approval is based on data from the Phase III FIDELIO-DKD renal outcomes study
Read More
US approval for OTC use of Bayer’s Astepro
Approval makes Astepro the first and only OTC steroid free antihistamine nasal spray available in the US
Read More
Bayer subsidiary doses first patient with Parkinson’s disease cell therapy
German pharma company announces progress in its ‘two-pronged’ cell and gene therapy approach to Parkinson’s disease
Read More
Bayer’s Xarelto approved in the UK
First oral factor Xa inhibitor approved for paediatric venous thromboembolism
Read More
Bayer establishes new cell and gene therapy platform
Platform will enable Bayer to pursue external collaborations and bolster internal capabilities
Read More
Bayer inks deal with Blackford Analysis to develop radiology AI platform
Agreement will aim to develop a platform to support radiologists’ decision-making
Read More
Bayer’s Nubeqa wins NICE prostate cancer backing
Drug authorised for use in non-metastatic castration-resistant prostate cancer
Read More
- MRM Health collaborates with Oncode Institute and Netherlands Cancer Institute
- Sobi to acquire Arthrosi Therapeutics, strengthening gout treatment pipeline
- Lindus Health and Quotient Sciences announce strategic partnership to accelerate drug development
- Title21 Health Solutions joins the Blood and Cells Advocacy Roster
- NADMED launches $30,000 metabolomics research award
